Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

TY1 and Semaglutide to Treat Cardiometabolic HFpEF

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingTY1 and Semaglutide to Treat Cardiometabolic HFpEF

CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingCRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia

Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

Stem Cell-Based Cartilage Tissue Regeneration

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingStem Cell-Based Cartilage Tissue Regeneration

Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingAutologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence

Transplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingTransplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders

Advancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Continue ReadingAdvancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders

Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Research Objective Our objective is to enable scalable genetic screening to study how different cell types and epigenetic networks are impacted by risk genes implicated in human psychiatric disorders. Impact…

Continue ReadingTranslational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo

Identifying and Overcoming Roadblocks to Hearing Restoration Using Human Induced Pluripotent Stem Cells

  • Post author:
  • Post published:September 14, 2026
  • Post category:

Research Objective To utilize human iPSCs as an in vitro model of hearing loss and overcome obstacles to hair cell regeneration by prompting post-mitotic supporting cells to re-enter the cell…

Continue ReadingIdentifying and Overcoming Roadblocks to Hearing Restoration Using Human Induced Pluripotent Stem Cells
  • Go to the previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 60
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us